Zhonglin Yang

1.9k total citations
54 papers, 1.6k citations indexed

About

Zhonglin Yang is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Zhonglin Yang has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Pharmacology and 7 papers in Complementary and alternative medicine. Recurrent topics in Zhonglin Yang's work include Natural product bioactivities and synthesis (20 papers), Pharmacological Effects of Natural Compounds (9 papers) and Phytochemical Studies and Bioactivities (8 papers). Zhonglin Yang is often cited by papers focused on Natural product bioactivities and synthesis (20 papers), Pharmacological Effects of Natural Compounds (9 papers) and Phytochemical Studies and Bioactivities (8 papers). Zhonglin Yang collaborates with scholars based in China, United States and Hong Kong. Zhonglin Yang's co-authors include Ping Li, Fei Li, Chun-Feng Zhang, Chang-Run Guo, Xiaolin Yang, Chunfeng Zhang, Xiaolin Yang, Zhenzhong Wang, Wenzhe Huang and Dongli Qi and has published in prestigious journals such as Journal of Clinical Oncology, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Zhonglin Yang

53 papers receiving 1.6k citations

Peers

Zhonglin Yang
Mee-Young Lee South Korea
Gabsik Yang South Korea
Qi Dong China
Zhonglin Yang
Citations per year, relative to Zhonglin Yang Zhonglin Yang (= 1×) peers Somasundaram Arumugam

Countries citing papers authored by Zhonglin Yang

Since Specialization
Citations

This map shows the geographic impact of Zhonglin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonglin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonglin Yang more than expected).

Fields of papers citing papers by Zhonglin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonglin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonglin Yang. The network helps show where Zhonglin Yang may publish in the future.

Co-authorship network of co-authors of Zhonglin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonglin Yang. A scholar is included among the top collaborators of Zhonglin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonglin Yang. Zhonglin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhenlin, Nan Yao, Jing Zhou, et al.. (2022). Antiosteosarcoma effects of novel 23-nor-3,4-seco-3-acetallupane triterpenoids from Acanthopanax gracilistylus W.W. Smith var. gracilistylus in 143B cells. Fitoterapia. 158. 105126–105126. 3 indexed citations
2.
Yang, Xiaolin, et al.. (2019). Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats. Molecules. 24(7). 1268–1268. 31 indexed citations
3.
Wu, Hui, et al.. (2017). Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats. Biomedicine & Pharmacotherapy. 96. 727–735. 29 indexed citations
4.
Li, Fei, Jianping Bi, Ye Jin, et al.. (2016). Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D–phospholipid complex. International Journal of Nanomedicine. Volume 11. 4919–4929. 30 indexed citations
5.
Li, Fei, Xiaolin Yang, Yanan Yang, et al.. (2015). Phospholipid complex as an approach for bioavailability enhancement of echinacoside. Drug Development and Industrial Pharmacy. 41(11). 1777–1784. 35 indexed citations
6.
Yang, Min, Xiaolin Yang, Wei Xiao, et al.. (2015). Comparative pharmacokinetic profiles of tectorigenin in rat plasma by UPLC–MS/MS after oral administration of Iris tectorum Maxim extract and pure tectoridin. Journal of Pharmaceutical and Biomedical Analysis. 114. 34–41. 27 indexed citations
7.
Li, Fei, Jinyang Shen, Xiaolin Yang, Zhonglin Yang, & Junping Kou. (2015). Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil. Drug Design Development and Therapy. 9. 4685–4685. 20 indexed citations
8.
Meng, Zhaoqing, Zhaohui Tang, Chang-Run Guo, et al.. (2015). Anti-Hyperuricemic and Nephroprotective Effects of Rhein in Hyperuricemic Mice. Planta Medica. 81(4). 279–285. 54 indexed citations
9.
Liang, Yan, Xiaolin Yang, Zhaoqing Meng, et al.. (2014). Simultaneous quantification of Akebia saponin D and its five metabolites in human intestinal bacteria using ultra-performance liquid chromatography triple quadrupole mass spectrometry. Journal of Chromatography B. 971. 81–88. 13 indexed citations
10.
Guo, Chang-Run, Chun-Feng Zhang, Li Lu, et al.. (2014). Hypoglycemic and hypolipidemic effects of oxymatrine in high-fat diet and streptozotocin-induced diabetic rats. Phytomedicine. 21(6). 807–814. 59 indexed citations
11.
Li, Fei, Xiaolin Yang, Ya‐Nan Yang, et al.. (2013). Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine. 20(6). 549–557. 77 indexed citations
12.
Han, Deen, Yi Zheng, Xijing Chen, et al.. (2012). Identification and Characterization of Human UDP-glucuronosyltransferases Responsible for the In Vitro Glucuronidation of Salvianolic Acid A. Drug Metabolism and Pharmacokinetics. 27(6). 579–585. 7 indexed citations
13.
Li, Fei, Ya‐Nan Yang, Panpan Zhu, et al.. (2012). Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia. 83(8). 1443–1450. 66 indexed citations
14.
Wang, Linna, Lin Ma, Ran You, et al.. (2012). Akebia saponin D attenuates ibotenic acid-induced cognitive deficits and pro-apoptotic response in rats: Involvement of MAPK signal pathway. Pharmacology Biochemistry and Behavior. 101(3). 479–486. 37 indexed citations
15.
Chen, Lvyi, Huafeng Yin, Zhou Lan, et al.. (2011). Anti-hyperuricemic and nephroprotective effects of Smilax china L.. Journal of Ethnopharmacology. 135(2). 399–405. 83 indexed citations
17.
Li, Kai, Li Ding, Zhonglin Yang, et al.. (2009). Determination of asperosaponin VI in rat plasma by HPLC‐ESI‐MS and its application to preliminary pharmacokinetic studies. Biomedical Chromatography. 24(5). 550–555. 19 indexed citations
18.
Hu, Yongmei, Chuan Liu, Ka‐Wing Cheng, et al.. (2008). Sesquiterpenoids from Homalomena occulta affect osteoblast proliferation, differentiation and mineralization in vitro. Phytochemistry. 69(12). 2367–2373. 39 indexed citations
19.
Zhang, Chunfeng, et al.. (2007). Effects of cinnamene enhancers on transdermal delivery of ligustrazine hydrochloride. European Journal of Pharmaceutics and Biopharmaceutics. 67(2). 413–419. 36 indexed citations
20.
Zhang, Chunfeng, Zhonglin Yang, & Luo Jia-bo. (2006). Effects of Enantiomer and Isomer Permeation Enhancers on Transdermal Delivery of Ligustrazine Hydrochloride. Pharmaceutical Development and Technology. 11(4). 417–424. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026